Eisai Listed for 22nd Consectutive Year In FTSE4Good Index Series, An Index for Socially Responsible Investment Aug 04, 2023 12:04 HKT/SGT Read More
Healthcare Hiring on the rise in the Philippines: foundit Insights Tracker Aug 02, 2023 12:35 HKT/SGT Read More
Vasileios Mingos Joins Health-ISAC as European Operations Director Aug 01, 2023 21:16 HKT/SGT Read More
Vasileios Mingos Joins Health-ISAC as European Operations Director Aug 01, 2023 21:00 HKT/SGT Read More
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology Aug 01, 2023 20:14 HKT/SGT Read More
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology Aug 01, 2023 20:00 HKT/SGT Read More
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management Jul 31, 2023 21:00 JST Read More
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management Jul 31, 2023 20:00 HKT/SGT Read More
Exploring New Collaborative Opportunities! The Indonesia-China Healthcare and Biotech Investment Forum Successfully Held Jul 31, 2023 19:48 HKT/SGT Read More
LAC FullCal and LAC Joint Protec: Stronger Bones and Healthier Joints for Pregnant/Postpartum Mothers Jul 31, 2023 08:00 HKT/SGT Read More
LAC FullCal and LAC Joint Protec: Stronger Bones and Healthier Joints for Pregnant/Postpartum Mothers Jul 31, 2023 08:00 HKT/SGT Read More
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients Jul 28, 2023 06:00 HKT/SGT Read More
VapeEZ Launches NEXCORE DUAL BOOST: Pioneering Brand with Ultra High Capacity Dual Mesh Technology Jul 26, 2023 20:00 HKT/SGT Read More
VapeEZ Launches NEXCORE DUAL BOOST: Pioneering Brand with Ultra High Capacity Dual Mesh Technology Jul 26, 2023 20:00 HKT/SGT Read More
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed Jul 26, 2023 18:58 HKT/SGT Read More